annual EBITDA:
$650.86M+$341.17M(+110.16%)Summary
- As of today (July 1, 2025), BMRN annual EBITDA is $650.86 million, with the most recent change of +$341.17 million (+110.16%) on December 31, 2024.
- During the last 3 years, BMRN annual EBITDA has risen by +$603.42 million (+1272.16%).
- BMRN annual EBITDA is now at all-time high.
Performance
BMRN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$263.02M+$67.53M(+34.54%)Summary
- As of today (July 1, 2025), BMRN quarterly EBITDA is $263.02 million, with the most recent change of +$67.53 million (+34.54%) on March 31, 2025.
- Over the past year, BMRN quarterly EBITDA has increased by +$126.58 million (+92.77%).
- BMRN quarterly EBITDA is now at all-time high.
Performance
BMRN quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$777.11M+$126.58M(+19.46%)Summary
- As of today (July 1, 2025), BMRN TTM EBITDA is $777.11 million, with the most recent change of +$126.58 million (+19.46%) on March 31, 2025.
- Over the past year, BMRN TTM EBITDA has increased by +$420.77 million (+118.08%).
- BMRN TTM EBITDA is now at all-time high.
Performance
BMRN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BMRN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +110.2% | +92.8% | +118.1% |
| 3 y3 years | +1272.2% | +59.1% | +392.6% |
| 5 y5 years | +1939.2% | +96.0% | +310.9% |
BMRN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1272.2% | at high | +3007.2% | at high | +340.2% |
| 5 y | 5-year | at high | +1939.2% | at high | +804.5% | at high | >+9999.0% |
| alltime | all time | at high | +193.2% | at high | +148.3% | at high | +211.3% |
BMRN EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $263.02M(+34.5%) | $777.11M(+19.5%) |
| Dec 2024 | $650.86M(+110.2%) | $195.50M(+25.0%) | $650.53M(+29.1%) |
| Sep 2024 | - | $156.41M(-3.6%) | $503.81M(+20.4%) |
| Jun 2024 | - | $162.17M(+18.9%) | $418.52M(+17.5%) |
| Mar 2024 | - | $136.44M(+179.7%) | $356.34M(+16.2%) |
| Dec 2023 | $309.69M(+16.0%) | $48.77M(-31.4%) | $306.77M(+15.1%) |
| Sep 2023 | - | $71.13M(-28.9%) | $266.46M(+19.5%) |
| Jun 2023 | - | $99.98M(+15.1%) | $222.91M(+19.3%) |
| Mar 2023 | - | $86.88M(+926.4%) | $186.90M(-29.6%) |
| Dec 2022 | $266.92M(+462.7%) | $8.46M(-69.3%) | $265.36M(+20.9%) |
| Sep 2022 | - | $27.58M(-56.9%) | $219.56M(+24.4%) |
| Jun 2022 | - | $63.98M(-61.3%) | $176.53M(+11.9%) |
| Mar 2022 | - | $165.34M(-542.8%) | $157.75M(+232.6%) |
| Dec 2021 | $47.43M(-43.3%) | -$37.34M(+141.6%) | $47.43M(-30.4%) |
| Sep 2021 | - | -$15.45M(-134.2%) | $68.19M(+16.3%) |
| Jun 2021 | - | $45.20M(-17.8%) | $58.65M(+1397.4%) |
| Mar 2021 | - | $55.02M(-431.8%) | $3.92M(-95.3%) |
| Dec 2020 | $83.66M(+162.1%) | -$16.58M(-33.6%) | $83.13M(-31.1%) |
| Sep 2020 | - | -$24.98M(+162.1%) | $120.62M(-36.2%) |
| Jun 2020 | - | -$9.53M(-107.1%) | $189.11M(-0.2%) |
| Mar 2020 | - | $134.23M(+542.0%) | $189.44M(+503.1%) |
| Dec 2019 | $31.92M(-1047.1%) | $20.91M(-51.9%) | $31.41M(+1076.0%) |
| Sep 2019 | - | $43.50M(-573.2%) | $2.67M(-111.7%) |
| Jun 2019 | - | -$9.19M(-61.4%) | -$22.77M(+115.6%) |
| Mar 2019 | - | -$23.80M(+204.0%) | -$10.56M(+213.4%) |
| Dec 2018 | -$3.37M(-103.7%) | -$7.83M(-143.4%) | -$3.37M(-103.4%) |
| Sep 2018 | - | $18.05M(+498.0%) | $98.57M(+9.1%) |
| Jun 2018 | - | $3.02M(-118.2%) | $90.34M(+29.0%) |
| Mar 2018 | - | -$16.61M(-117.7%) | $70.02M(-23.0%) |
| Dec 2017 | $90.97M(-113.0%) | $94.11M(+857.9%) | $90.97M(-237.1%) |
| Sep 2017 | - | $9.82M(-156.8%) | -$66.36M(-36.4%) |
| Jun 2017 | - | -$17.31M(-498.9%) | -$104.42M(-83.5%) |
| Mar 2017 | - | $4.34M(-106.9%) | -$632.28M(-9.4%) |
| Dec 2016 | -$698.01M(+861.6%) | -$63.22M(+123.9%) | -$698.01M(+34.1%) |
| Sep 2016 | - | -$28.24M(-94.8%) | -$520.43M(-7.4%) |
| Jun 2016 | - | -$545.17M(+788.2%) | -$561.97M(+667.5%) |
| Mar 2016 | - | -$61.38M(-153.7%) | -$73.22M(+9.1%) |
| Dec 2015 | -$72.59M(+58.9%) | $114.36M(-263.9%) | -$67.09M(-70.9%) |
| Sep 2015 | - | -$69.78M(+23.7%) | -$230.15M(+70.9%) |
| Jun 2015 | - | -$56.42M(+2.1%) | -$134.63M(+60.5%) |
| Mar 2015 | - | -$55.25M(+13.5%) | -$83.88M(+95.1%) |
| Dec 2014 | -$45.69M(-65.2%) | -$48.70M(-289.2%) | -$42.98M(+23.0%) |
| Sep 2014 | - | $25.74M(-554.3%) | -$34.94M(-64.8%) |
| Jun 2014 | - | -$5.67M(-60.5%) | -$99.22M(-1.2%) |
| Mar 2014 | - | -$14.36M(-64.7%) | -$100.44M(-14.7%) |
| Dec 2013 | -$131.12M(+94.9%) | -$40.65M(+5.5%) | -$117.75M(+3.9%) |
| Sep 2013 | - | -$38.54M(+459.2%) | -$113.32M(+55.2%) |
| Jun 2013 | - | -$6.89M(-78.2%) | -$73.04M(-14.5%) |
| Mar 2013 | - | -$31.66M(-12.6%) | -$85.47M(+31.0%) |
| Dec 2012 | -$67.26M(>+9900.0%) | -$36.23M(-2178.4%) | -$65.26M(+56.5%) |
| Sep 2012 | - | $1.74M(-109.0%) | -$41.70M(-19.3%) |
| Jun 2012 | - | -$19.32M(+68.6%) | -$51.65M(+126.8%) |
| Mar 2012 | - | -$11.46M(-9.5%) | -$22.77M(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$172.00K(-101.0%) | -$12.66M(+54.1%) | -$171.00K(-104.4%) |
| Sep 2011 | - | -$8.21M(-185.9%) | $3.93M(-78.6%) |
| Jun 2011 | - | $9.56M(-14.2%) | $18.35M(-1.2%) |
| Mar 2011 | - | $11.14M(-230.1%) | $18.58M(+8.9%) |
| Dec 2010 | $17.07M(-52.1%) | -$8.56M(-237.9%) | $17.07M(-54.0%) |
| Sep 2010 | - | $6.21M(-36.6%) | $37.08M(-19.7%) |
| Jun 2010 | - | $9.79M(+1.7%) | $46.18M(-5.4%) |
| Mar 2010 | - | $9.63M(-16.0%) | $48.80M(+37.0%) |
| Dec 2009 | $35.63M(-47.2%) | $11.46M(-25.1%) | $35.63M(-40.2%) |
| Sep 2009 | - | $15.31M(+23.4%) | $59.56M(+2.2%) |
| Jun 2009 | - | $12.41M(-450.0%) | $58.28M(+2.4%) |
| Mar 2009 | - | -$3.54M(-110.0%) | $56.92M(-8.7%) |
| Dec 2008 | $67.43M(-227.4%) | $35.40M(+152.4%) | $62.38M(+244.0%) |
| Sep 2008 | - | $14.02M(+26.9%) | $18.14M(-249.8%) |
| Jun 2008 | - | $11.05M(+478.3%) | -$12.10M(-66.1%) |
| Mar 2008 | - | $1.91M(-121.6%) | -$35.66M(-33.1%) |
| Dec 2007 | -$52.92M(+255.6%) | -$8.85M(-45.4%) | -$53.27M(-3.0%) |
| Sep 2007 | - | -$16.22M(+29.6%) | -$54.89M(+38.2%) |
| Jun 2007 | - | -$12.51M(-20.3%) | -$39.70M(+60.4%) |
| Mar 2007 | - | -$15.70M(+49.9%) | -$24.76M(+74.5%) |
| Dec 2006 | -$14.88M(-72.7%) | -$10.47M(+916.5%) | -$14.18M(+0.7%) |
| Sep 2006 | - | -$1.03M(-142.2%) | -$14.09M(-40.8%) |
| Jun 2006 | - | $2.44M(-147.6%) | -$23.81M(-44.1%) |
| Mar 2006 | - | -$5.12M(-50.6%) | -$42.62M(-21.8%) |
| Dec 2005 | -$54.47M(-59.5%) | -$10.38M(-3.4%) | -$54.47M(-55.3%) |
| Sep 2005 | - | -$10.74M(-34.4%) | -$121.89M(-10.1%) |
| Jun 2005 | - | -$16.37M(-3.6%) | -$135.61M(+0.9%) |
| Mar 2005 | - | -$16.97M(-78.2%) | -$134.46M(-0.1%) |
| Dec 2004 | -$134.63M(+102.9%) | -$77.80M(+218.0%) | -$134.63M(+69.2%) |
| Sep 2004 | - | -$24.47M(+60.7%) | -$79.56M(+9.2%) |
| Jun 2004 | - | -$15.23M(-11.2%) | -$72.84M(+12.0%) |
| Mar 2004 | - | -$17.14M(-24.6%) | -$65.05M(-2.0%) |
| Dec 2003 | -$66.36M(+12.2%) | -$22.73M(+28.1%) | -$66.36M(-2.4%) |
| Sep 2003 | - | -$17.74M(+138.5%) | -$68.00M(+8.1%) |
| Jun 2003 | - | -$7.44M(-59.7%) | -$62.93M(-5.1%) |
| Mar 2003 | - | -$18.46M(-24.3%) | -$66.29M(+12.1%) |
| Dec 2002 | -$59.12M(+45.5%) | -$24.37M(+92.4%) | -$59.12M(+13.4%) |
| Sep 2002 | - | -$12.66M(+17.3%) | -$52.15M(+11.1%) |
| Jun 2002 | - | -$10.80M(-4.4%) | -$46.95M(+6.4%) |
| Mar 2002 | - | -$11.29M(-35.1%) | -$44.13M(+12.1%) |
| Dec 2001 | -$40.63M(+35.7%) | -$17.40M(+132.9%) | -$39.38M(+14.9%) |
| Sep 2001 | - | -$7.47M(-6.3%) | -$34.28M(+3.4%) |
| Jun 2001 | - | -$7.97M(+21.8%) | -$33.15M(+8.1%) |
| Mar 2001 | - | -$6.54M(-46.8%) | -$30.68M(+2.4%) |
| Dec 2000 | -$29.94M(+46.9%) | -$12.30M(+94.1%) | -$29.94M(+25.7%) |
| Sep 2000 | - | -$6.34M(+15.5%) | -$23.82M(+2.3%) |
| Jun 2000 | - | -$5.49M(-5.5%) | -$23.28M(+2.7%) |
| Mar 2000 | - | -$5.81M(-6.1%) | -$22.68M(+10.8%) |
| Dec 1999 | -$20.38M(+68.5%) | -$6.18M(+6.6%) | -$20.47M(+43.3%) |
| Sep 1999 | - | -$5.80M(+18.6%) | -$14.28M(+68.4%) |
| Jun 1999 | - | -$4.89M(+36.0%) | -$8.48M(+136.0%) |
| Mar 1999 | - | -$3.59M | -$3.59M |
| Dec 1998 | -$12.10M | - | - |
FAQ
- What is BioMarin Pharmaceutical annual EBITDA?
- What is the all time high annual EBITDA for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual EBITDA year-on-year change?
- What is BioMarin Pharmaceutical quarterly EBITDA?
- What is the all time high quarterly EBITDA for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly EBITDA year-on-year change?
- What is BioMarin Pharmaceutical TTM EBITDA?
- What is the all time high TTM EBITDA for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical TTM EBITDA year-on-year change?
What is BioMarin Pharmaceutical annual EBITDA?
The current annual EBITDA of BMRN is $650.86M
What is the all time high annual EBITDA for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual EBITDA is $650.86M
What is BioMarin Pharmaceutical annual EBITDA year-on-year change?
Over the past year, BMRN annual EBITDA has changed by +$341.17M (+110.16%)
What is BioMarin Pharmaceutical quarterly EBITDA?
The current quarterly EBITDA of BMRN is $263.02M
What is the all time high quarterly EBITDA for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly EBITDA is $263.02M
What is BioMarin Pharmaceutical quarterly EBITDA year-on-year change?
Over the past year, BMRN quarterly EBITDA has changed by +$126.58M (+92.77%)
What is BioMarin Pharmaceutical TTM EBITDA?
The current TTM EBITDA of BMRN is $777.11M
What is the all time high TTM EBITDA for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high TTM EBITDA is $777.11M
What is BioMarin Pharmaceutical TTM EBITDA year-on-year change?
Over the past year, BMRN TTM EBITDA has changed by +$420.77M (+118.08%)